In RA patients, the expression of SUMO1 and SUMO2 is elevated in fibroblast‐like synoviocytes (FLSs), especially SUMO1, and FLSs are important for promoting RA pathogenesis. Here, SUMO2 is linked to rheumatoid arthritis.